KMT2Ar Adversely Impacts Brexucabtagene Autoleucel (Brexu-cel) Outcome in Adults with Relapsed/ Refractory (r/r) B-Cell Acute Lymphoblastic Leukemia.
Abdullah Ladha(University of Southern California), Caspian Oliai(APLA Health), Joshua Sasine(Cedars-Sinai Medical Center), Catherine J. Lee(University of Utah), Matthew L. Ulrickson, George Yaghmour(University of Tennessee Health Science Center), María Silvina Odstrcil Bobillo(University of Utah), Paul Shaughnessy(CHRISTUS Transplant Institute), Navneet S. Majhail(Sarah Cannon), Divya Koura(University of California San Diego), Marlise R. Luskin(Dana-Farber Cancer Institute), Vinod Pullarkat(City of Hope), Sumithira Vasu(The Ohio State University), Bijal Shah(Boston College), Jacob Boccucci(Augusta University Health), Luke Mountjoy(Colorado Blood Cancer Institute), Evandro D. Bezerra(Cleveland Clinic), Tamer Othman(City Of Hope National Medical Center), Noam E. Kopmar(University of Washington), Evan C. Chen(Dana-Farber Cancer Institute), Rasmus T. Hoeg(University of California, Davis), LaQuisa C. Hill(Baylor College of Medicine), Ibrahim N. Muhsen, Shahbaz Malik, Vamsi Kota(Augusta University), Caitlin Guzowski(Northside Hospital), Muthu V. Kumaran(University of Arkansas for Medical Sciences), Veronika Bachanová(University of Minnesota), Talal Hilal(WinnMed), Chenyu Lin(Duke University), Aaron C. Logan(University of California, San Francisco), Ryan D. Cassaday(University of Washington), Minoo Battiwalla(Sarah Cannon), Kaitlyn C. Dykes(University of California San Diego), John A. Mathews(Macquarie University), Anjali S. Advani(Cleveland Clinic), Ran Reshef(Abramson Cancer Center), Yannis K. Valtis(Brigham and Women's Hospital), Virginia Tan(Oregon Health & Science University), Timothy E. O’Connor(University of Northern Iowa), Nikeshan Jeyakumar(Stanford Blood Center), Amy Zhang, Mohamed Ahmed(The University of Texas MD Anderson Cancer Center), Jae H. Park(Memorial Sloan Kettering Cancer Center), Maryann Stefan(Cleveland Clinic), Katharine Miller(Stanford University), Melhem Solh(Johns Hopkins Hospital), Ali Al Darobi(The University of Texas MD Anderson Cancer Center), Rawan Faramand(Moffitt Cancer Center)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862